| Review: |
This monograph on blood, plasma and plasma proteins is Volume 7 of Pharmaceuticals Policy and Law and brings together a collection of papers by international authors. The text is arranged in eight main sections entitled: The issue and the history; Labile blood components; Plasma-derived medicinal products; Legislation and regulations; Supply, availability and needs; Financing; Integrating blood, plasma and plasma derivatives; Future trends. The section on plasma-derived products includes papers written from the patients' perspective, as well as the perspective of doctors on current and future uses of blood and plasma products. All contributing chapters are supported by reference lists and the book includes a useful glossary. |